Velcade-Based Triplet Regimen ‘Should Remain’ Standard of Care in Newly Diagnosed Multiple … A triplet regimen of Kyprolis (carfilzomib), Revlimid and dexamethasone (KRd) was not superior to the standard of care Velcade (bortezomib), Revlimid (lenalidomide) and dexamethasone(VRd) in patients with newly diagnosed standard- or intermediate-risk multiple myeloma, according to data published in The Lancet Oncology. […]

BioSpace Movers & Shakers, Sept. 11 Metrion – Metrion Biosciences Limited named Anca Harlambie as its head of Business Development. Harlambie will represent the U.K.-based company across Europe and the United Kingdom. Additionally, Mari Kennedy will support Metrion in the mid-west and east coast of the United States. In Japan, Metrion will be represented by […]

Treatment Options for Multiple Myeloma – Mayo Clinic In the third of a four-part video series on multiple myeloma, Vivek Roy, M.D., hematologist and director of the bone marrow transplant program at Mayo Clinic in Florida, discusses treatment options for myeloma. To learn more about Multiple Myeloma, visit: https://mayocl.in/2N4dM48 View this entire #MultipleMyeloma playlist at: […]

Eton’s much loved baker Michael Cadwallader dies aged 78 The man whose bakery supplied the people of Eton and its famous college with cakes for special occasions over many years has died aged 78. Michael Cadwallader took over Eton’s bakery in 1979 after moving to the town with his wife Monaliza and their two children. […]

2019 Multiple Myeloma Symposium | Current & Future Treatment Kenneth C. Anderson, MD details the short- and long-term treatment for multiple myeloma and discusses the promising advances over the horizon. Innovations range from new drugs and approaches to new ways of combining existing drugs.